TY  - JOUR
AU  - van Straalen, Kelsey R
AU  - Tzellos, Thrasyvoulos
AU  - Guillem, Phillipe
AU  - Benhadou, Farida
AU  - Cuenca-Barrales, Carlos
AU  - Daxhelet, Mathilde
AU  - Daoud, Mathieu
AU  - Efthymiou, Ourania
AU  - Giamarellos-Bourboulis, Evangelos J
AU  - Jemec, Gregor B E
AU  - Katoulis, Alexandros C
AU  - Koenig, Anke
AU  - Lazaridou, Elizabeth
AU  - Marzano, Angelo V
AU  - Matusiak, Łucas
AU  - Molina-Leyva, Alejandro
AU  - Moltrasio, Chiara
AU  - Pinter, Andreas
AU  - Potenza, Concetta
AU  - Romaní, Jorge
AU  - Saunte, Ditte M
AU  - Skroza, Nevena
AU  - Stergianou, Dimitra
AU  - Szepietowski, Jacek
AU  - Trigoni, Anastasia
AU  - Vilarrasa, Eva
AU  - van der Zee, Hessel H
PY  - 2021
DO  - 10.1016/j.jaad.2020.12.089
UR  - http://hdl.handle.net/10668/17028
T2  - Journal of the American Academy of Dermatology
AB  - Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current hidradenitis suppurativa guidelines. However, evidence for their efficacy is drawn from small studies, often without validated...
LA  - en
KW  - acne inversa
KW  - antibiotics
KW  - clindamycin
KW  - doxycycline
KW  - efficacy
KW  - guideline
KW  - minocycline
KW  - outcome
KW  - rifampicin
KW  - tetracycline
KW  - therapy
KW  - treatment
KW  - Adult
KW  - Clindamycin
KW  - Cohort Studies
KW  - Drug Combinations
KW  - Europe
KW  - Female
KW  - Hidradenitis Suppurativa
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Rifampin
KW  - Tetracyclines
KW  - Treatment Outcome
TI  - The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
TY  - research article
VL  - 85
ER  -